Anti-nuclear antibodies (ANA) targeting a range of cellular proteins are detected in the sera of up to 95% of SSc patients (Beck et al., 1963; Mierau et al., 2011), some of which have diagnostic utility in distinguishing SSc from other connective tissue diseases. Here, BTG3 is linked to systemic sclerosis.